// App-Quantinova.ai

4001 : The anti-CD47 antibody Hu5F9-G4 activates macrophages and inhibits ovarian cancer xenografts, alone and in combination with chemotherapy or immunotherapy

Researchers

Presenter

  • Rishil J. Kathawala

Principal Investigators

  • David C. Mundy

  • George E. Duran

  • Jens-Peter Volkmer

  • Kevin S. Kao

  • Yan C. Wang

  • Aditi Bellary

  • Irving L. Weissman

  • Branimir I. Sikic

Medical Centers

  • Stanford University Hospital, Stanford, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Carboplatin

  • Trastuzumab

  • Paclitaxel

  • Erbitux

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved